Introduction of pyrrolidineoxy or piperidineamino group at the 4-position of quinazoline leading to novel quinazoline-based phosphoinositide 3-kinase delta (PI3Kδ) inhibitors
Author:
Affiliation:
1. Department of Medicinal Chemistry, School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an, P.R. China
Funder
National Natural Science Foundation of China
China Postdoctoral Science Foundation
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14756366.2018.1444608
Reference20 articles.
1. Targeting the phosphoinositide 3-kinase pathway in cancer
2. Present and Future of PI3K Pathway Inhibition in Cancer: Perspectives and Limitations
3. Targeting PI3Kδ: Emerging Therapy for Chronic Lymphocytic Leukemia and Beyond
4. Targeting the B cell receptor pathway in chronic lymphocytic leukemia
5. PI3Kδ Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PI3Kδ and mTOR dual inhibitors: Design, synthesis and anticancer evaluation of 3-substituted aminomethylquinoline analogues;Bioorganic Chemistry;2024-06
2. Design, synthesis and biological evaluation of novel selective PI3Kδ inhibitors containing pyridopyrimidine scaffold;Future Medicinal Chemistry;2023-08
3. Research advances on selective phosphatidylinositol 3 kinase δ (PI3Kδ) inhibitors;Bioorganic & Medicinal Chemistry Letters;2020-10
4. Synthesis and biological activity of new 2,4,6-trisubstituted triazines as potential phosphoinositide 3-kinase inhibitors;Journal of Chemical Research;2020-02-11
5. Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer;European Journal of Medicinal Chemistry;2019-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3